HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEN on nano-sunscreens

This article was originally published in The Rose Sheet

Executive Summary

The use of nanoparticles in sunscreen formulations may be raising unnecessary alarm, Andrew Maynard, chief science advisor for the Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars, suggested during a Jan. 14 presentation in Washington. "There are going to be many products which use nanoscale materials which are no more dangerous than products that use non-nanomaterials," he said. That is not to say that further research is not warranted; Maynard noted that distinguishing between safe and unsafe sunscreens will require a "better level of knowledge" than currently is had. In fall 2008, Consumers Union issued a report packaged as an exposé of sunscreens that are marketed as nanotech-free but actually contain nanoparticles, possibly signaling a need for greater transparency from industry, as well as for consumer education (1"The Rose Sheet" Nov. 10, 2008, p. 3). Nanoparticles increasingly are being used in dietary supplements as well, and William B. Schultz, former FDA deputy commissioner for policy, thinks FDA should be granted the authority to regulate such products more intensively

You may also be interested in...



Consumer Effort To Unmask Nanotech Users Begs Question: Why Wear Masks?

A Consumers Union report being billed as an exposé of sunscreens that are marketed as nanotech-free but actually contain nanoparticles may signal a need not for FDA's intervention but for industry to take the lead in educating consumers on nanotechnology

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel